F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) Sees Significant Growth in Short Interest

F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) was the recipient of a large increase in short interest during the month of August. As of August 14th, there was short interest totaling 18,771 shares, an increase of 63.9% from the July 30th total of 11,453 shares. Based on an average daily volume of 3,579 shares, the short-interest ratio is presently 5.2 days. Currently, 0.7% of the company’s stock are sold short.

F/m Emerald Life Sciences Innovation ETF Price Performance

F/m Emerald Life Sciences Innovation ETF stock opened at $45.70 on Wednesday. F/m Emerald Life Sciences Innovation ETF has a 1-year low of $27.67 and a 1-year high of $48.78. The business has a fifty day moving average price of $46.20 and a 200-day moving average price of $40.26.

Institutional Investors Weigh In On F/m Emerald Life Sciences Innovation ETF

An institutional investor recently raised its position in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC lifted its holdings in shares of F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) by 8.3% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 49,739 shares of the company’s stock after acquiring an additional 3,831 shares during the period. Hunter Associates Investment Management LLC owned approximately 1.86% of F/m Emerald Life Sciences Innovation ETF worth $1,736,000 at the end of the most recent quarter.

About F/m Emerald Life Sciences Innovation ETF

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.